Was a little surprised with some of the forecast dose sales for next year.
Sales of only 35 doses for HCC 1st line. There must be an order of magnitude of pts who can't tolerate SOR?And if the OS is the same, and the AE are less and the QOL better, then 35 is questionable, IMO.
Upgraded to a buy, page-3
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.81M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 11.0¢ | $47.54K | 413.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 738789 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 294345 | 2 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
12.0¢ |
Change
0.000 ( 4.35 %) |
||||
| Open | High | Low | Volume | ||
| 11.3¢ | 12.0¢ | 11.3¢ | 559635 | ||
| Last updated 15.59pm 01/05/2024 ? | |||||
| SRX (ASX) Chart |